Showing 401-410 of 9807 results for "".
SDPA: Medical Director Dr. Hilary Baldwin on Conference Planning Process
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-conference-planning-process/29507/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. Dr. Baldwin shares insights on the process of planning SDPA.SDPA: Sara Wilchowski Talks About Transitioning to Industry and Understanding How Nutraceuticals Can Help Patients
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-sara-wilchowski-talks-about-transitioning-to-industry-and-understanding-how-nutraceuticals-can-help-patients/29513/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Sara Wilchowski, DMSc, MPAS, PA-C. Wilchowski is currently a senior medical science liaison and joined a panel of MSLs to discuss the ins and outs of transitioning to industry. Following the panel, she gave a lScience of Skincare Summit 2024: Social Media as Education Tool
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-social-media-as-education-tool/29448/Jennifer Liu, MD, a dermatologist and social media influencer (dermfluencer) talks with Practical Dermatology about using social media at a tool to educate various audiences with correct information about both products and conditions such as atopic dermatitis and psoriasis. This video was recorded aMore than Skin Deep: Sharing Stories for Mental Health
https://practicaldermatology.com/topics/general-topics/more-skin-deep-sharing-stories-mental-health/28860/Medical students Emily Woolhiser and Alexandra Lawlor highlight an empowering project seeking to address issues stemming from psychological issues due to dermatological conditions.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroPediatric Roundup: Pearls from SDPA Summer Conference 2024
https://practicaldermatology.com/conferences/sdpa-2024/pediatric-roundup-pearls-sdpa-summer-2024/26273/Lisa Swanson, MD, FAAD, a pediatric dermatologist at Saint Luke’s Children’s Hospital and Summer 2024 SDPA Conference Medical Director, presented a whirlwind tour of common and uncommon pediatric dermatological conditions, as well as the current treatments for the conditions.Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.Social Media as a Force for Good: How to Think Like a B Corp
https://practicaldermatology.com/topics/practice-management/social-media-as-a-force-for-good-how-to-think-like-a-b-corp/24009/For dermatologists, social media networks are underutilized when marketing their practices—create quality and trusted material, deliver practice-specific messaging strategies, and convey and sustain reliable information.Stand Out From the Pack
https://practicaldermatology.com/topics/practice-management/stand-out-from-the-pack/23975/How to get ahead of National Healthy Skin Month.To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.